Evidence map›Paper›PMID 42028283›Full record

ArticleMaterials today. Bio2026

Strontium and gallium doping enhances

Irene Lodoso-Torrecilla, Daniel Moreno, Gaël Ciucci, Miguel Mateu-Sanz, Ji-Young Yoon, Emilio Jimenez-Pique, Jordi Franch, Maria-Cristina Manzanares, Joanna Konka, Montserrat Espanol and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irene Lodoso-TorrecillaDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Daniel MorenoDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Gaël CiucciDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Miguel Mateu-SanzDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Ji-Young YoonDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Emilio Jimenez-PiqueBarcelona Research Centre for Multiscale Science and Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Jordi FranchBone Healing Group, Small Animal Surgery Department, Veterinary School, Universitat Autonoma de Barcelona, Bellaterra, Barcelona, 08193, Spain.
Maria-Cristina ManzanaresHuman Anatomy and Embryology Unit, Department of Pathology and Experimental Therapeutics, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, 08907, Spain.
Joanna KonkaDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Montserrat EspanolDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
Maria-Pau GinebraDepartment of Materials Science and Engineering, Group of Biomaterials, Biomechanics and Tissue Engineering, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doping of calcium phosphates (CaPs) with bioinorganic ions is a widely used strategy to enhance their biological performance in bone regeneration. However, conventional methods for ionic incorporation in CaP scaffolds often require high-temperature treatments or involve multiple complex steps. Here, we present two simple strategies to dope 3D-printed CaP scaffolds via incorporation of ions into the apatitic phase during the hydrolysis of α-tricalcium phosphate (α-TCP) to calcium deficient hydroxyapatite (CDHA). In the first strategy, ions were incorporated directly into the printing ink, whereas in the second, undoped robocasted scaffolds were immersed in ionic solutions, allowing ion incorporation into precipitated CDHA during phase transformation. We investigated several ions, including strontium (Sr

Indexed as

3D printingBiomimetic hydroxyapatiteBone regenerationCalcium phosphatesIon dopingOsteoinductionScaffold

Identifiers

PMID42028283
PMCPMC13101743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.